Advanced Biomaterial Systems

Advanced Biomaterial Systems (ABS) is a Taiwan-based biotechnology company specializing in the development and manufacturing of microfluidic-based point-of-care testing (POCT) solutions. The company's core technology integrates complex laboratory processes onto a single microfluidic chip, enabling rapid and precise diagnostic results from minimal sample volumes. Their product portfolio primarily focuses on critical care and infectious disease markers, including assays for sepsis and cardiovascular health. By leveraging its proprietary "Lab-on-a-Chip" platform, ABS aims to bridge the gap between centralized laboratory testing and bedside patient care. The company provides both the diagnostic instruments and the consumable cartridges required for high-sensitivity testing in clinical settings. ABS's solutions are designed to improve patient outcomes by providing actionable clinical data within minutes, facilitating timely medical decisions.